Leandro Jonata Carvalho Oliveira, Medical Oncologist at Einstein Hospital Israelita, shared a post on LinkedIn:
“Liquid Biopsy in Cancer Screening and Minimal Residual Disease Assessment: Are We Ready for Clinical Practice?
During the I Simpósio de Genômica e Oncologia de Precisão, we discussed current evidence on the use of liquid biopsy in cancer screening and early disease management (MRD)—including stages of clinical development, limitations, and future prospects.
In a table coordinated by Dr. Anamaria Aranha Camargo and Dr. Jorge Sabagga, alongside Dr. Fabiana Bettoni and Dr. Helano Freitas, who brought excellent presentations, we explored different scenarios for the application of liquid biopsy in oncological practice.
A very high level event, organized by Dr. Giovana Torrezan and Dr. Gabriel Macedo, MSc, PhD, bringing together national experts in genomics and precision oncology.”
Other articles about Liquid Biopsy on OncoDaily.